Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flea cuticular chitin is a rigid, crystalline polysaccharide polymer composed of β-1,4-linked N-acetylglucosamines, forming α-chitin nanofibrils (2-3 nm diameter) that self-assemble into microfibrils embedded in a protein matrix to create the insect exoskeleton. Synthesized by the epidermal-specific chitin synthase CHS-A, it provides mechanical strength, water impermeability, and protection against dehydration, injury, and predation, while also serving as a scaffold for chitin-binding proteins with Rebers-Riddiford (R&R) or CBM14 domains. Partial deacetylation by chitin deacetylases (CDAs) enables proper laminar organization, pore canal formation, and locomotion; deficiencies lead to structural defects, growth arrest, or molting failure where insects are trapped in old cuticles. During molting, old chitin is degraded by GH18 chitinases, GH20 hexosaminidases, and lytic polysaccharide monooxygenases (LPMOs) to allow shedding and new cuticle deposition. In fleas and other insects, this chitin is targeted by insecticides like chitin synthesis inhibitors, which disrupt procuticle formation, causing lethality without direct mammalian toxicity due to species-specific CHS enzymes. Key supporting details from sources: Structure and synthesis: Chitin bundles (18-25 chains) form orthorhombic α-crystallites with antiparallel chains stabilized by hydrogen bonds; synthesized from UDP-N-acetylglucosamine by plasma membrane-bound CHS-A oligomers, distinct from midgut CHS-B for peritrophic matrix chitin. Modifications and assembly: Nascent chains are partially deacetylated and organized into helicoidal Bouligand structures with cuticular proteins for plywood-like rigidity; proteins like Knickkopf (KNK) and CPAPs protect chitin from premature degradation. Physiological roles: Essential across life stages (eggshell, serosal cuticle, larval/adult exoskeleton); mutations or RNAi knockdowns cause embryo lethality, muscle detachment, fragile elytra, and mortality. Therapeutic targeting: As a veterinary/insecticide target in fleas (e.g., rat flea digestive tract associations), CHS inhibitors block chitin production, leading to incomplete cuticles and death; no human disease roles noted.
Inhibition of chitin synthase (CHS-A); Disruption of chitin fibril assembly; Increased susceptibility to chitin degradation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flea cuticular chitin.